Dysport and Progesterone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Dysport (abobotulinumtoxina) and Progesterone (progesterone). Common drug interactions include drug ineffective among females.

The phase IV clinical study analyzes what interactions people have when they take Dysport and Progesterone. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Dysport?

Dysport has active ingredients of abobotulinumtoxina. It is often used in wrinkles. eHealthMe is studying from 6,349 Dysport users. Check the latest studies of Dysport.

What is Progesterone?

Progesterone has active ingredients of progesterone. It is often used in menopause. eHealthMe is studying from 21,021 Progesterone users. Check the latest studies of Progesterone.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 25, 2026

25 people who take Dysport and Progesterone together, and have interactions are studied.

Dysport and Progesterone drug interactions.

What are the common drug interactions of Dysport and Progesterone, by gender? *:

female:

Drug ineffective
Overdose
Fatigue (feeling of tiredness)
Injection site erythema (redness at injection site)
Swelling face
Dysarthria (speech disorder)
Gait disturbance
Limb discomfort (discomfort in leg)
Mydriasis (a dilation of the pupil)
Pain

male:

n/a

What are the common drug interactions of Dysport and Progesterone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Disturbance in attention
Dizziness
Dyspnoea (difficult or laboured respiration)
Myalgia (muscle pain)
Neuropathy peripheral (surface nerve damage)
Paralysis
Urinary tract infection

30-39:

Mydriasis (a dilation of the pupil)
Photophobia (extreme sensitivity to light)
Vision blurred
Headache (pain in head)
Injection site pain
Swelling face
Urticaria (rash of round, red welts on the skin that itch intensely)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Negative thoughts
Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)

40-49:

Drug ineffective
Urticaria (rash of round, red welts on the skin that itch intensely)
Fatigue (feeling of tiredness)
Infection
Oropharyngeal pain
Rash
Swelling face

50-59:

Drug ineffective
Dry mouth
Dysarthria (speech disorder)
Gait disturbance
Limb discomfort (discomfort in leg)
Pain
Paraesthesia oral (sensation of tingling, tickling, prickling, pricking, or burning of a person's oral with no apparent long-term physical effect)
Swollen tongue (swelling of tongue)
Dizziness
Ear infection

60+:

Drug ineffective
Dysphonia (speech disorder attributable to a disorder of phonation)
Fatigue (feeling of tiredness)
Injection site erythema (redness at injection site)
Injection site swelling
Nasopharyngitis (inflammation of the nasopharynx)
Nausea (feeling of having an urge to vomit)
Urinary incontinence (inability to control the flow of urine and involuntary urination)
Vertigo
Body temperature increased

What are the existing conditions these people have? *

Skin Wrinkling (wrinkle on skin): 20 people, 80.00%
Menopausal Symptoms: 3 people, 12.00%

* Approximation only. Some reports may have incomplete information.

Do you take Dysport and Progesterone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously